Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
02/2007
02/21/2007CN1915971A Prostaglandin-like compound and its uses for treatment of external secretion disorders
02/21/2007CN1915429A Combinations of the peroxisome proliferator-activated receptor (ppar) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications
02/21/2007CN1915428A Synergistic therapeutic compositions and methods
02/21/2007CN1915399A Preparation for treating high blood pressure, high blood fat, obesity, and climacteric syndrome, and preparation method
02/21/2007CN1915344A Nutrient for cell growth, preparation method, and application of finished product in treating tumor, cardiovascular and cerebrovascular diseases
02/21/2007CN1915325A Medication for treating heart disease
02/21/2007CN1915318A Medicinal composition, preparation method and quality control method
02/21/2007CN1915317A Medicinal composition, preparation method and quality control method
02/21/2007CN1915316A Medicinal composition, preparation method and quality control method
02/21/2007CN1915306A Medicinal composition, preparation method and quality control method
02/21/2007CN1915305A Medicinal composition, preparation method and quality control method
02/21/2007CN1915304A Medicinal composition, preparation method and quality control method
02/21/2007CN1915301A Drop pills of corydalis tuber, and preparation method
02/21/2007CN1915295A Medicinal composition, preparation method and quality control method
02/21/2007CN1915294A Medicinal composition, preparation method and quality control method
02/21/2007CN1915293A Medicinal composition, preparation method and quality control method
02/21/2007CN1915292A Application of acetylcholine esterase inhibitor medication of Yidancao extractive as cholinomimetic
02/21/2007CN1915287A Medicinal composition, preparation method and quality control method
02/21/2007CN1915286A Medicinal composition, preparation method and quality control method
02/21/2007CN1915285A Medicinal composition, preparation method and quality control method
02/21/2007CN1915283A Medicinal composition, preparation method and quality control method
02/21/2007CN1915282A Medicinal composition, preparation method and quality control method
02/21/2007CN1915281A Medicinal composition, preparation method and quality control method
02/21/2007CN1915279A Medicinal composition, preparation method and quality control method
02/21/2007CN1915278A Medicinal composition, preparation method and quality control method
02/21/2007CN1915277A Medicinal composition, preparation method and quality control method
02/21/2007CN1915275A Medicinal composition, preparation method and quality control method
02/21/2007CN1915274A Medicinal composition, preparation method and quality control method
02/21/2007CN1915273A Medicinal composition, preparation method and quality control method
02/21/2007CN1915272A Medicinal composition, preparation method and quality control method
02/21/2007CN1915271A Medicinal composition, preparation method and quality control method
02/21/2007CN1915270A Medicinal composition, preparation method and quality control method
02/21/2007CN1915269A Medicinal composition, preparation method and quality control method
02/21/2007CN1915268A Medicinal composition, preparation method and quality control method
02/21/2007CN1915267A Medicinal composition, preparation method and quality control method
02/21/2007CN1915266A Medicinal composition, preparation method and quality control method
02/21/2007CN1915265A Medicinal composition, preparation method and quality control method
02/21/2007CN1915264A Medicinal composition, preparation method and quality control method
02/21/2007CN1915263A Medicinal composition, preparation method and quality control method
02/21/2007CN1915262A Preparation of Shuxiening injection, technique and adaptive disease
02/21/2007CN1915261A Preparation of 'thrombosis through' capsule, technique and adaptive disease
02/21/2007CN1915260A Drop pills containing general saponin of notoginseng, and preparation method
02/21/2007CN1915259A Medicinal composition, preparation method and quality control method
02/21/2007CN1915258A Medicinal composition, preparation method and quality control method
02/21/2007CN1915257A Medicinal composition, preparation method and quality control method
02/21/2007CN1915256A Medicinal composition, preparation method and quality control method
02/21/2007CN1915255A Medicinal composition, preparation method and quality control method
02/21/2007CN1915254A Medicinal composition, preparation method and quality control method
02/21/2007CN1915251A Medicinal composition, preparation method and quality control method
02/21/2007CN1915250A Medicinal composition, preparation method and quality control method
02/21/2007CN1915249A Medicinal composition, preparation method and quality control method
02/21/2007CN1915246A Medicinal composition, preparation method and quality control method
02/21/2007CN1915245A Medicinal composition, preparation method and quality control method
02/21/2007CN1915244A Medicaments of 'thrombosis through' freezed drying powder injection (including dedicated solvent) and technique and adaptive disease
02/21/2007CN1915237A Medicinal composition, preparation method and quality control method
02/21/2007CN1915234A New medicinal composition
02/21/2007CN1915231A Use of nonsteroidal in preparing drug of antiinflammatory agents
02/21/2007CN1915230A Injection in large capacity of sodium sulfonate containing tanshinone óÄA and preparation method
02/21/2007CN1915228A Soft capsule of indapamide
02/21/2007CN1915225A Drop pills of Amlodipine, and preparation method
02/21/2007CN1915224A Slowly released tablet of compound atenolol, and preparation method
02/21/2007CN1915222A Composition of liposome, and preparation method
02/21/2007CN1915218A Sodium sulfonate injection of tanshinone óÄA, and preparation method
02/21/2007CN1301323C Health beer and its preparation method
02/21/2007CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion
02/21/2007CN1301127C Technological method of preparing vessels and networks quiet injection preparation
02/21/2007CN1301117C Ginseng and aconite granules for treating qi vacuity and yang desertion and its preparation method
02/21/2007CN1301113C Method for making preparation of rhodiola root
02/21/2007CN1301098C Hairy holly root drip pill and its preparation method
02/21/2007CN1301097C Naoxinqing drip pill for treating heart drain blood vessel disease and its preparation method
02/20/2007US7179922 Chemical compounds
02/20/2007US7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors
02/20/2007US7179901 Renal regulatory elements and methods of use thereof
02/20/2007US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
02/20/2007US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
02/20/2007US7179826 Antiproliferative agnets; antitumor agents; anticancer agents; cardiovascular disorders; central nervous system disorders; autoimmune diseases; antiinflammatory agents
02/20/2007US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
02/20/2007US7179821 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain
02/20/2007US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid
02/20/2007US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors
02/20/2007US7179804 Tachykinin receptor antagonists
02/20/2007US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia
02/20/2007US7179792 Combination product of a 1,4-benzothiepine 1,1-dioxide compound with at least one other active ingredient and the use of the product
02/20/2007US7179790 Brain natriuretic peptide
02/20/2007US7179788 Synergistic mixtur eof glucangon-like peptide , in solid phase, and insulin solution, in liquid phase; antidiabetic agents; obesity
02/20/2007US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use
02/20/2007US7179647 For introducing DNA into organisms which produce large amounts of oils and, in particular, oils with a high content of unsaturated fatty acids
02/20/2007US7179632 Process for the production of allicin
02/20/2007US7179610 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state
02/20/2007US7179491 Contacting marine oil with an effective amount of a silica under a vacuum;contacting the oil with an effective amount of a bleaching clay;separating the silica from the oil; and separating the clay from the oil
02/20/2007US7179469 Beneficial effect of distiller's grain in cardiovascular disease
02/20/2007CA2422374C Purine derivatives
02/20/2007CA2404700C Novel method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril
02/20/2007CA2375225C Mutual salt of amlodipine and atorvastatin
02/20/2007CA2371174C Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
02/20/2007CA2344574C Thyroid receptor ligands
02/20/2007CA2335520C Adenosine derivatives
02/20/2007CA2263561C Thienopyrimidines
02/20/2007CA2218872C Preparation and use of sulfated oligosaccharides
02/20/2007CA2218499C Chemokine binding protein and methods of use therefor
1 ... 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 ... 1595